Tsai-Ta Lai
Net worth: 189 M $ as of 2026-07-30
Net worth: 189 M $ as of 2026-07-30
Tsai-Ta Lai held the position of Chief Technology Officer at AquaFresco, Inc., founded in 2015.
Dr. Lai is Chairman & Chief Executive Officer at Metis TechBio Co., Ltd., founded in 2020.
Dr. Lai is the founder of AquaFresco, Inc. (2015) and Metis TechBio Co., Ltd. (2020).
Dr. Lai is also the founder of METiS Therapeutics, Inc...
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-09 | 111,166,572 ( 10.26% ) | 143 M $ | 2026-07-30 | |
METIS TECHBIO CO., LTD. 36.55% | 2026-05-12 | 36,400,278 ( 36.55% ) | 47 M $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| METIS TECHBIO CO., LTD. | Chief Executive Officer | 2020-01-09 |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Producer Manufacturing |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
Select your edition
All financial news and data tailored to specific country editions